Menachem M. Inbar

HealOr Ltd. develops and commercializes proprietary biochemical regulatory therapeutics impacting skin cells properties for the purpose of treating various skin pathologies. Its leading drug, HO/03/03, is currently undergoing Phase II/III clinical trials in the United States and India. The company is also establishing a first-in-class therapeutic pipeline for additional skin pathologies such as chronic and acute wounds, dry skin, acne, psoriasis, and others. HealOr was founded by Tamar Tennenbaum in 2002 and is headquartered in Rechovot, Israel.

N.L.T Spine Ltd. develops spine surgery instrumentation and implants for treating degenerative spinal conditions. Its products include PROW FUSION and eSPIN System. The company was founded in 2006 by Didier Toubia and Tzony Siegal and is headquartered in Kfar Saba, Israel.

Meridian Bioscience Israel Ltd. engages in the development, manufacturing, marketing, and distribution of diagnostic and life science products. It offers its solutions to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies. The company was founded by Uri Geiger on April 11, 2006 and is headquartered in Modi'in-Maccabim-Re'ut, Israel.

Carmel Investment Group Ltd. manages and appraises real property for others. The private company is based in Ramat Gan, Israel.

Accelmed Ventures provides pharmaceutical and biotech technology services. The company was founded by Mori Arkin in 2009 and is headquartered in Miami, Florida.

ValCare Medical, Inc. engages in the designing, developing and commercializing devices and accessories for minimally invasive treatment of heart valve diseases. The firm develops a unique transcatheter device, which will provide the capability to implant the mitral annuloplasty device interventionally without surgery. The company was founded by Samuel M. Shaolian in 2012 and is headquartered in Herzlyia Pituach, Israel.